LIVE Panel Discussion, COVID-19: Strategic Implications on Biopharma

Please join us Thursday, April 2nd from 1-2 PM EST to listen to the LIVE panel, COVID 19: Strategic Implications on Biopharma. Following our COVID-19 thought leadership piece on the strategic implications for biopharma, our panelists look forward to taking a deeper...

Strategic Implications of COVID-19 on Biopharma

These are challenging times for governments, public health administrations and the financial markets. While each biopharma company’s primary concern is the health and safety of its team members, the industry also a responsibility to the world to take an active...

Deal Makers of Japan, Volume 1

Locust Walk has been active in Asia, in particular, Japan for nearly half of the firm’s history and we are deeply rooted in the market. We have advised on more than a dozen transactions during our history in Japan and have successfully helped deal making between US/EU...

2019 Year End Review Biopharma Report

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our 2019 Annual Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life sciences deal...